BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 15793190)

  • 1. The metabolic syndrome in older individuals: prevalence and prediction of cardiovascular events: the Cardiovascular Health Study.
    Scuteri A; Najjar SS; Morrell CH; Lakatta EG;
    Diabetes Care; 2005 Apr; 28(4):882-7. PubMed ID: 15793190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes.
    Lorenzo C; Williams K; Hunt KJ; Haffner SM
    Diabetes Care; 2007 Jan; 30(1):8-13. PubMed ID: 17192325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adult Treatment Panel III 2001 but not International Diabetes Federation 2005 criteria of the metabolic syndrome predict clinical cardiovascular events in subjects who underwent coronary angiography.
    Saely CH; Koch L; Schmid F; Marte T; Aczel S; Langer P; Hoefle G; Drexel H
    Diabetes Care; 2006 Apr; 29(4):901-7. PubMed ID: 16567835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of different metabolic syndrome definitions and risks of incident cardiovascular events in the elderly.
    Vinluan CM; Zreikat HH; Levy JR; Cheang KI
    Metabolism; 2012 Mar; 61(3):302-9. PubMed ID: 21840552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of NCEP-ATPIII and IDF metabolic syndrome definitions with relation to metabolic syndrome-associated sexual dysfunction.
    Corona G; Mannucci E; Petrone L; Schulman C; Balercia G; Fisher AD; Chiarini V; Forti G; Maggi M
    J Sex Med; 2007 May; 4(3):789-796. PubMed ID: 17498109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The metabolic syndrome and incidence of cardiovascular disease in non-diabetic subjects--a population-based study comparing three different definitions.
    Nilsson PM; Engström G; Hedblad B
    Diabet Med; 2007 May; 24(5):464-72. PubMed ID: 17381496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study.
    de Simone G; Devereux RB; Chinali M; Best LG; Lee ET; Galloway JM; Resnick HE;
    Diabetes Care; 2007 Jul; 30(7):1851-6. PubMed ID: 17440172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of age and gender on the prevalence and prognostic importance of the metabolic syndrome and its components in Europeans. The MORGAM Prospective Cohort Project.
    Vishram JK; Borglykke A; Andreasen AH; Jeppesen J; Ibsen H; Jørgensen T; Palmieri L; Giampaoli S; Donfrancesco C; Kee F; Mancia G; Cesana G; Kuulasmaa K; Salomaa V; Sans S; Ferrieres J; Dallongeville J; Söderberg S; Arveiler D; Wagner A; Tunstall-Pedoe H; Drygas W; Olsen MH;
    PLoS One; 2014; 9(9):e107294. PubMed ID: 25244618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of criteria for metabolic syndrome in a population-based study of Japanese-Brazilians.
    Rosenbaum P; Gimeno SG; Sanudo A; Franco LJ; Ferreira SR;
    Diabetes Obes Metab; 2005 Jul; 7(4):352-9. PubMed ID: 15955121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes.
    Tong PC; Kong AP; So WY; Yang X; Ho CS; Ma RC; Ozaki R; Chow CC; Lam CW; Chan JC; Cockram CS
    Diabetes Care; 2007 May; 30(5):1206-11. PubMed ID: 17259472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men.
    Lakka HM; Laaksonen DE; Lakka TA; Niskanen LK; Kumpusalo E; Tuomilehto J; Salonen JT
    JAMA; 2002 Dec; 288(21):2709-16. PubMed ID: 12460094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic interactions between cardiovascular risk factors.
    Vishram JK
    Dan Med J; 2014 Jul; 61(7):B4892. PubMed ID: 25123126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Tale of Three Gorges in the Yangtze River: Comparing the Prevalence of Metabolic Syndrome According to ATPIII, WHO, and IDF Criteria and the Association with Vascular Health in Modernizing China.
    Woo KS; Hu YJ; Chook P; Wei AN; Chan R; Yin YH; Celermajer DS
    Metab Syndr Relat Disord; 2019 Apr; 17(3):137-142. PubMed ID: 30835162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older.
    Alexander CM; Landsman PB; Teutsch SM; Haffner SM; ;
    Diabetes; 2003 May; 52(5):1210-4. PubMed ID: 12716754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of metabolic syndrome by the Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions and their association with coronary heart disease in an elderly Iranian population.
    Hadaegh F; Zabetian A; Tohidi M; Ghasemi A; Sheikholeslami F; Azizi F
    Ann Acad Med Singap; 2009 Feb; 38(2):142-9. PubMed ID: 19271043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does the impact of metabolic syndrome on cardiovascular events vary by using different definitions?
    Khosravi-Boroujeni H; Ahmed F; Sadeghi M; Roohafza H; Talaei M; Dianatkhah M; Pourmogaddas A; Sarrafzadegan N
    BMC Public Health; 2015 Dec; 15():1313. PubMed ID: 26715355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in traditional and emerging cardiovascular risk factors of subjects discordantly classified by metabolic syndrome definitions of the International Diabetes Federation and the National Cholesterol Education Program.
    Boronat M; Saavedra P; Varillas VF; Wagner AM; López-Plasencia Y; Alberiche MP; Nóvoa FJ
    Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):417-22. PubMed ID: 18819785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective study of metabolic syndrome as a mortality marker in chronic coronary heart disease patients.
    Mayer O; Bruthans J; Seidlerová J; Karnosová P; Vaněk J; Hronová M; Gelžinský J; Cvíčela M; Wohlfahrt P; Cífková R; Filipovský J
    Eur J Intern Med; 2018 Jan; 47():55-61. PubMed ID: 28755847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low ankle-brachial pressure index predicts increased risk of cardiovascular disease independent of the metabolic syndrome and conventional cardiovascular risk factors in the Edinburgh Artery Study.
    Wild SH; Byrne CD; Smith FB; Lee AJ; Fowkes FG
    Diabetes Care; 2006 Mar; 29(3):637-42. PubMed ID: 16505519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic disorders and cardiovascular risk in people living with HIV/AIDS without the use of antiretroviral therapy.
    Raposo MA; Armiliato GNA; Guimarães NS; Caram CA; Silveira RDS; Tupinambás U
    Rev Soc Bras Med Trop; 2017; 50(5):598-606. PubMed ID: 29160505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.